Byotrol PLC Senior Management Appointment (1208Y)

TIDMBYOT

RNS Number : 1208Y

Byotrol PLC

12 January 2022

Byotrol plc

("Byotrol" or the "Company")

Senior Management Appointment

Byotrol plc (AIM: BYOT), the infection prevention technology company, is pleased to announce the appointment of Vivan Pinto as Chief Growth Officer (CGO) of the Company.

Vivan is an experienced commercial leader with a blue-chip career spanning 20 years at Johnson and Johnson, Reckitt Benckiser and Pfizer, where he held senior positions in General Management, Commercial and Marketing across the globe. His most recent position was Area Managing Director for J&J Consumer Health Africa.

At Byotrol, Vivan will be leading and growing our consumer business and will also be central to developing group strategy. His arrival completes a series of recent investments in upgrading Byotrol's operational leadership team, across the sales, marketing, business development, strategy, finance and technology functions.

Vivan graduated from Duke University, North Carolina, with a BSc in Biology before completing a MSc in IP Law from Queen Mary's College and an MBA from Imperial College, both in London. At the date of this announcement, he holds 200,000 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares") representing approximately 0.04 per cent. of the Company.

Commenting on the appointment, David Traynor, CEO of Byotrol plc, said:

"We are delighted to welcome Vivan Pinto into the team. He has an excellent track record in leading and growing very successful businesses across B2B and B2C. We are all looking forward to working with him."

Enquiries:

 
 Byotrol Plc 
 John Langlands - Chairman 
  David Traynor - Chief Executive 
  Chris Sedwell - Chief Finance Officer                    [phone] 
 
 finnCap (Nominated Adviser and Broker)                    [phone] 
 Geoff Nash/Kate Bannatyne/George Dollemore 
  - Corporate Finance 
 Richard Chambers - ECM 
 
 Flagstaff Strategic and Investor Communications           [phone] 
 Tim Thompson/Andrea Seymour/Fergus Mellon          [e-mail] 
 

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCBBMFTMTJBBRT

(END) Dow Jones Newswires

January 12, 2022 02:00 ET (07:00 GMT)